ACTB and esophageal cancer: However, some other studies found the opposite results, suggesting that ACTB was up-regulated in some cancers, such as esophageal cancer (ES) and NSCLC (not typed) compared to normal samples [42,43], and a study showed that up-regulated ACTB was associated with poor prognosis in LUAD [39].